(Press-News.org) ALEXANDRIA, Va. – New studies released today reveal important advances in cancer care quality measurement, physician adherence to quality standards, and end-of-life care, while highlighting the overuse of contralateral prophylactic mastectomy. The studies were released in a presscast today in advance of ASCO's inaugural 2012 Quality Care Symposium. The Symposium will take place November 30 – December 1, 2012, at the Manchester Grand Hyatt in San Diego.
Four major studies were highlighted in today's presscast:
Study finds that most preventive double mastectomies occur in women who are at very low risk for contralateral breast cancer: Analysis of two new patient surveys found that two thirds of women with early-stage breast cancer who underwent contralateral prophylactic mastectomy were not at elevated risk for cancer in the contralateral breast; researchers found that women who opted for preventive double mastectomy had a high degree of worry about recurrence.
A multidisciplinary team approach to end-of-life care communications leads to reduced use of intensive care among patients with advanced cancer: Researchers found that consultation from a multidisciplinary team increased the election of palliative care and decreased use of more intensive care measures (e.g., long-term ventilation and ICU support) among patients with advanced cancer hospitalized at a comprehensive cancer center over a four year period.
ASCO's quality evaluation program documents significant improvement in adherence to quality standards: An analysis of self-reported data from 156 oncology practices participating in ASCO's Quality Oncology Practice Initiative (QOPI®) showed that – over a four year period – adherence to many quality care standards markedly improved, especially those involving new standard practices (e.g., genetic testing for tumor mutations, use of new anti-nausea drugs, etc.).
A real-time electronic performance tracking system improves adherence to quality care standards for breast and colon cancers: A large study found that use of a quality reporting system developed by the American College of Surgeons was associated with improved adherence to certain quality standards at 64 cancer centers over a four-year period. The electronic performance tracking system evaluated in this study is the first to provide real-time feedback.
"Ensuring that our patients receive the highest quality care possible is a core responsibility of oncology. The studies presented today show us new strategies for measuring and improving our adherence to quality standards," said Jyoti Patel, MD, ASCO Cancer Communications Committee member. "The findings also provide insight on discussing treatment options for patients with both early-stage and advanced cancers."
This year's Quality Care Symposium will include more than 330 abstracts covering topics, such as reducing overuse of tests and procedures, improving patient-physician communication, effectively measuring quality of care, and applying advanced health information technology to improve the quality and value of care.
###
Information for Media: www.asco.org/QCSpresskit
Additional Resources for Patients and Reporters:
Cancer.Net, ASCO's award-winning cancer information website provides comprehensive, oncologist-approved information on more than 120 cancer types, together with expert information on cancer treatments, managing side effects and coping with a cancer diagnosis. This year Cancer.Net celebrates 10 years of helping patients. When the site first launched in 2002, there were detailed sections on 22 different types of cancer. Now, Cancer.Net continues to lead the way in content, design, and interactivity, providing patients, their families and friends with timely and authoritative information.
ASCO's CancerProgress.Net offers a detailed, interactive timeline of advances against 14 of the most common cancers, including progress in lymphoma, colorectal, brain, prostate and breast cancers. The site also includes simple, interactive charts on cancer survival, mortality, and incidence, along with historical commentary and other reporting resources.
To view the full release click here: http://www.asco.org/ASCOv2/Department%20Content/Communications/Downloads/QCS%20Research%20Release.pdf
ATTRIBUTION TO THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY QUALITY CARE SYMPOSIUM IS REQUESTED IN ALL NEWS COVERAGE.
Funding for this conference was made possible in part by a grant (1 R13 HS021377-01) from the Agency for Healthcare Research and Quality (AHRQ). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
About ASCO
The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 30,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.Cancer.Net.
Research from ASCO'S Quality Care Symposium shows advances and challenges in improving the quality of cancer care
2012-11-28
ELSE PRESS RELEASES FROM THIS DATE:
Fish ear bones point to climate impacts
2012-11-28
Scientists believe that fish ear bones and their distinctive growth rings can offer clues to the likely impacts of climate change in aquatic environments.
The earbones, or 'otoliths', help fish to detect movement and to orient themselves in the water. Otoliths set down annual growth rings that can be measured and counted to estimate the age and growth rates of fish.
"Otoliths can form the basis of new techniques for modelling fish growth, productivity and distribution in future environments," said Dr John Morrongiello of CSIRO's Wealth from Oceans Flagship, lead author ...
4 is the 'magic' number
2012-11-28
According to psychological lore, when it comes to items of information the mind can cope with before confusion sets in, the "magic" number is seven.
But a new analysis by a leading Australian professor of psychiatry challenges this long-held view, suggesting the number might actually be four.
In 1956, American psychologist George Miller published a paper in the influential journal Psychological Review arguing the mind could cope with a maximum of only seven chunks of information.
The paper, "The Magical Number Seven, Plus or Minus Two. Some Limits on Our Capacity ...
Biggest black hole blast discovered
2012-11-28
Quasars are the intensely luminous centres of distant galaxies that are powered by huge black holes. This new study has looked at one of these energetic objects – known as SDSS J1106+1939 – in great detail, using the X-shooter instrument on ESO's VLT at the Paranal Observatory in Chile [1]. Although black holes are noted for pulling material in, most quasars also accelerate some of the material around them and eject it at high speed.
"We have discovered the most energetic quasar outflow known to date. The rate that energy is carried away by this huge mass of material ...
Potentially toxic flame retardants found in many US couches
2012-11-28
DURHAM, N.C. -- More than half of all couches tested in a Duke University-led study contained potentially toxic or untested chemical flame retardants that may pose risks to human health.
Among the chemicals detected was "Tris," a chlorinated flame retardant that is considered a probable human carcinogen based on animal studies.
"Tris was phased out from use in baby pajamas back in 1977 because of its health risks, but it still showed up in 41 percent of the couch foam samples we tested," said Heather Stapleton, associate professor of environmental chemistry at ...
80 percent of parents interested in genetic risk assessment for siblings of children with autism
2012-11-28
Cambridge, MA (November 28, 2012)--The vast majority (80 percent) of parents with at least one child with Autism Spectrum Disorder (ASD) would pursue genetic testing if a test were available that could identify risk in a younger sibling, citing the desire for earlier identification of children at risk, earlier evaluation and intervention, closer monitoring and lessened anxiety. The findings were reported in "Parental Interest in a Genetic Risk Assessment Test for Autism Spectrum Disorders," a survey published online today in the journal Clinical Pediatrics.
The survey ...
WSU researchers use 3-D printer to make parts from moon rock
2012-11-28
PULLMAN, Wash. - Imagine landing on the moon or Mars, putting rocks through a 3-D printer and making something useful – like a needed wrench or replacement part.
"It sounds like science fiction, but now it's really possible," says Amit Bandyopadhyay, professor in the School of Mechanical and Materials Engineering at Washington State University.
Bandyopadhyay and a group of colleagues recently published a paper in Rapid Prototyping Journal demonstrating how to print parts using materials from the moon.
Bandyopadhyay and Susmita Bose, professor in the School of Mechanical ...
Treating cocaine dependence: A promising new pharmacotherapy
2012-11-28
Philadelphia, PA, November 28, 2012 – Medication development efforts for cocaine dependence have yet to result in an FDA approved treatment. The powerful rewarding effects of cocaine, the profound disruptive impact of cocaine dependence on one's lifestyle, and the tendency of cocaine to attract people who make poor life choices and then exacerbate impulsive behavior all make cocaine a vexing clinical condition.
In this battle, many candidate pharmacotherapies have been tested, but none have succeeded sufficiently to be adopted widely. Perhaps like cancer, heart disease, ...
Brain cell transplants in early 2013
2012-11-28
As part of the European study TRANSEURO, five patients with Parkinson's disease will undergo brain cell transplants at Skåne University Hospital in Lund, Sweden, in early 2013. These are the first operations of their kind in Europe for over 10 years.
The TRANSEURO study, which in Sweden is led by Lund University, is now taking a critical approach to the viability of cell therapy as a future treatment for Parkinson's disease. Can we replace cells that die as a result of our most common neurological diseases? What are the therapies of the future for neurodegenerative diseases ...
Report finds Big Pharma is doing more for access to medicine in developing countries
2012-11-28
Amsterdam, the Netherlands: The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts to improve access to medicine in developing countries, finds that the industry is doing more than it was two years ago, with GlaxoSmithKline still outperforming its peers, but an expanding group of leaders closing the gap.
The Index, published Wednesday, found that Johnson & Johnson was one of the most dramatic risers, climbing from the middle of the field in 9th position in the 2010 Index to 2nd this year, closely behind GlaxoSmithKline. It ...
Anthropological expertise facilitates multicultural women's health care
2012-11-28
Collaboration between medical and anthropological expertise can solve complex clinical problems in today's multicultural women's healthcare, shows Pauline Binder, a medical anthropologist, who will present her thesis on 1 December at the Faculty of Medicine, Uppsala University, Sweden.
Pauline Binder has applied in-depth medical anthropological research approaches to understand clinical problems in ways not possible using only statistics. Why pregnant Somali women have an increased risk of complications even after migration has been the starting point for her fieldwork. ...